PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis

References

• Brodsky R A. Paroxysmal nocturnal hemoglobinuria. Hematology: Basic principles and practice4^th ed, R Hoffman, E J Benz, Jr, S J Shattil, B Furie, H J Cohen, L E Silberstein, P McGlave. Elsevier Churchill Livingstone, Philadelphia 2005; 419–427
   Google Scholar
• Moyo V M, Mukhina G L, Garrett E S, Brodsky R A. Natural history of paroxysmal nocturnal hemoglobinuria using modern diagnostic assays. Br J Haematol 2004; 126: 133–138
   PubMed Web of Science ®Google Scholar
• Socie G, Mary J Y, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996; 348: 573–577
   PubMed Web of Science ®Google Scholar
• Hillmen P, Lewis S M, Bessler M, Luzzatto L, Dacie J V. Natural history of paroxysmal nocturnal hemoglobinuria. N Eng J Med 1995; 333: 1253–1258
   PubMed Web of Science ®Google Scholar
• Nagarajan S, Brodsky R A, Young N S, Medof M E. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995; 86: 4656–4661
   PubMed Web of Science ®Google Scholar
• Tichelli A, Gratwohl A, Nissen C, Speck B. Late clonal complications in severe aplastic anemia. Leukemia & Lymphoma 1994; 12: 167–175
   PubMed Web of Science ®Google Scholar
• Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993; 259: 1318–1320
   PubMed Web of Science ®Google Scholar
• Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, et al. Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N Eng J Med 1994; 330: 249–255
   PubMed Web of Science ®Google Scholar
• Bessler M, Mason P J, Hillmen P, Miyata T, Yamada N, Takeda J, et al. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO Journal 1994; 13: 110–117
   PubMed Web of Science ®Google Scholar
• Araten D J, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proceedings of the National Academy of Sciences (USA) 1999; 96: 5209–5214
   PubMed Web of Science ®Google Scholar
• Hertenstein B, Wagner B, Bunjes D, Duncker C, Raghavachar A, Arnold R, et al. Emergence of CD52−, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of campath-1H for refractory B-cell non-Hodgkin lymphoma. Blood 1995; 86: 1487–1492
   PubMed Web of Science ®Google Scholar
• Rawstron A C, Rollinson S J, Richards S, Short M A, English A, Morgan G J, et al. The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment. Br J Haematol 1999; 107: 148–153
   PubMed Web of Science ®Google Scholar
• Ware R E, Pickens C V, DeCastro C M, Howard T A. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes. Experimental Hematology 2001; 29: 1403–1409
   PubMed Web of Science ®Google Scholar
• Hu R, Mukhina G L, Piantadosi S, Barber J P, Jones R J, Brodsky R A. PIG-A mutations in normal hematopoiesis. Blood 2005; 105: 3848–3854
   PubMed Web of Science ®Google Scholar
• Inoue N, Watanabe R, Takeda J, Kinoshita T. PIG-C, one of the three human genes involved in the first step of glycosylphosphatidylinositol biosynthesis is a homologue of Saccharomyces cerevisiae GPI2. Biochemistry & Biophysics Research Communications 1996; 226: 193–199
   PubMed Web of Science ®Google Scholar
• Kamitani T, Chang H M, Rollins C, Waneck G L, Yeh E T. Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk-cells by a human cDNA clone. J Biol Chem 1993; 268: 20733–20736
   PubMed Web of Science ®Google Scholar
• Tiede A, Schubert J, Nischan C, Jensen I, Westfall B, Taron C H, et al. Human and mouse Gpi1p homologues restore glycosylphosphatidylinositol membrane anchor biosynthesis in yeast mutants. Biochem J 1998; 334: 609–616
   PubMed Web of Science ®Google Scholar
• Watanabe R, Inoue N, Westfall B, Taron C H, Orlean P, Takeda J, et al. The first step of glycosylphosphatidylinositol biosynthesis is mediated by a complex of PIG-A, PIG-H, PIG-C and GPI1. EMBO J 1998; 17: 877–885
   PubMed Web of Science ®Google Scholar
• Murakami Y, Siripanyaphinyo U, Hong Y, Tashima Y, Maeda Y, Kinoshita T. The initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-Y, a seventh component. Molecular Biology of the Cell 2005; 16: 5236–5246
   PubMed Web of Science ®Google Scholar
• Watanabe R, Murakami Y, Marmor M D, Inoue N, Maeda Y, Hino J, et al. Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-P and is regulated by DPM2. EMBO J 2000; 19: 4402–4411
   PubMed Web of Science ®Google Scholar
• Watanabe R, Ohishi K, Maeda Y, Nakamura N, Kinoshita T. Mammalian PIG-L and its yeast homologue Gpi12p are N-acetylglucosaminylphosphatidylinositol de-N-acetylases essential in glycosylphosphatidylinositol biosynthesis. Biochem J 1999; 339: 185–192
   PubMed Web of Science ®Google Scholar
• Stevens V L. Biosynthesis of glycosylphosphatidylinositol membrane anchors. Biochem J 1995; 310: 361–370
   PubMed Web of Science ®Google Scholar
• Ferguson M A, Williams A F. Cell-surface anchoring of proteins via glycosylphosphatidylinositol structures. Annual Reviews in Biochemistry 1988; 57: 285–320
   PubMed Web of Science ®Google Scholar
• Kinoshita T, Inoue N. Dissecting and manipulating the pathway for glycosylphosphatidylinositol-anchor biosynthesis. Current Opinions in Chemical Biology 2000; 4: 632–638
   PubMed Web of Science ®Google Scholar
• Devine D V, Gluck W L, Rosse W F, Weinberg J B. Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. J Clin Invest 1987; 79: 314–317
   PubMed Web of Science ®Google Scholar
• Graham D L, Gastineau D A. Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy. Am J Med 1992; 93: 671–674
   PubMed Web of Science ®Google Scholar
• Longo L, Bessler M, Beris P, Swirsky D, Luzzatto L. Myelodysplasia in a patient with pre-existing paroxysmal nocturnal haemoglobinuria: a clonal disease orginating from within a clonal disease. Br J Haematol 1994; 87: 401–403
   PubMed Web of Science ®Google Scholar
• Araten D J, Swirsky D, Karadimitris A, Notaro R, Nafa K, Bessler M, et al. Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2001; 115: 360–368
   PubMed Web of Science ®Google Scholar
• Rosse W F. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine 1997; 76: 63–93
   PubMed Web of Science ®Google Scholar
• Hall S E, Rosse W F. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 5332–5340
   PubMed Web of Science ®Google Scholar
• Wilcox L A, Ezzell J L, Bernshaw N J, Parker C J. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood 1991; 78: 820–829
   PubMed Web of Science ®Google Scholar
• Medof M E, Kinoshita T, Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 1984; 160: 1558–1578
   PubMed Web of Science ®Google Scholar
• Hillmen P, Hall C, Marsh J C, Elebute M, Bombara M P, Petro B E, et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Eng J Med 2004; 350: 552–559
   PubMed Web of Science ®Google Scholar
• Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73: 703–711
   PubMed Web of Science ®Google Scholar
• Nafa K, Mason P J, Hillmen P, Luzzatto L, Bessler M. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood 1995; 86: 4650–4655
   PubMed Web of Science ®Google Scholar
• Johnson R J, Hillmen P. Paroxysmal nocturnal haemoglobinuria: nature's gene therapy. Mole Pathol 2002; 55: 145–152
   PubMedGoogle Scholar
• Bessler M, Hillmen P, Longo L, Luzzatto L, Mason P J. Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21. Human Mole Genet 1994; 3: 751–757
   PubMed Web of Science ®Google Scholar
• Nagarajan S, Brown C J, Medof M E. Identification of a PIG-A related processed gene on chromosome 12. Human Genetics 1995; 95: 691–697
   PubMed Web of Science ®Google Scholar
• Gerritsen W R, Donohue J, Bauman J, Jhanwar S C, Kernan N A, Castro-Malaspina H, et al. Clonal analysis of myelodysplastic syndrome: Monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992; 80: 217–224
   PubMed Web of Science ®Google Scholar
• Baurmann H, Cherif D, Berger R. Interphase cytogenetics by fluorescent in situ hybridization (FISH) for characterization of monosomy-7-associated myeloid disorders. Leukemia 1993; 7: 384–391
   PubMed Web of Science ®Google Scholar
• Fialkow P J, Jacobson R J, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977; 63: 125
   PubMed Web of Science ®Google Scholar
• Brodsky R A, Mukhina G L, Nelson K L, Lawrence T S, Jones R J, Buckley J T. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood 1999; 93: 1749–1756
   PubMed Web of Science ®Google Scholar
• Brodsky R A, Mukhina G L, Li S, Nelson K L, Chiurazzi P L, Buckley J T, et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000; 114: 459–466
   PubMed Web of Science ®Google Scholar
• Mukhina G L, Buckley J T, Barber J P, Jones R J, Brodsky R A. Multilineage glycosylphosphatidylinositol anchor deficient hematopoiesis in untreated aplastic anemia. Br J Haematol 2001; 115: 476–482
   PubMed Web of Science ®Google Scholar
• Howard S P, Buckley J T. Activation of the hole-forming toxin aerolysin by extracellular processing. J Bacteriol 1985; 163: 336–340
   PubMed Web of Science ®Google Scholar
• Schubert J, Vogt H G, Zielinska-Skowronek M, Freund M, Kaltwasser J P, Hoelzer D, et al. Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood 1994; 83: 2323–2328
   PubMed Web of Science ®Google Scholar
• Dunn D E, Tanawattanacharoen P, Boccuni P, Nagakura S, Green S W, Kirby M R, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Inter Med 1999; 131: 401–408
   PubMed Web of Science ®Google Scholar
• Wang H, Chuhjo T, Yasue S, Omine M, Nakao S. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 2002; 100: 3897–3902
   PubMed Web of Science ®Google Scholar
• Iwanaga M, Furukawa K, Amenomori T, Mori H, Nakamura H, Fuchigami K, et al. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol 1998; 102: 465–474
   PubMed Web of Science ®Google Scholar
• Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, et al. Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 2006; 107: 1308–1314
   PubMed Web of Science ®Google Scholar
• Matsui W H, Brodsky R A, Smith B D, Borowitz M J, Jones R J. Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia 2006; 20: 458–462
   PubMed Web of Science ®Google Scholar
• Taylor V C, Sims M, Brett S, Field M C. Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism. Biochem J 1997; 322: 919–925
   PubMed Web of Science ®Google Scholar
• Garland R J, Groves S J, Diamanti P, West S E, Winship K L, Virgo P F, et al. Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletion. Bone Marrow Transplant 2005; 36: 237–244
   PubMed Web of Science ®Google Scholar
• Endo M, Ware R E, Vreeke T M, Singh S P, Howard T A, Tomita A, et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 2546–2557
   PubMed Web of Science ®Google Scholar
• Noji H, Shichishima T, Saitoh Y, Kai T, Yamamoto T, Ogawa K, et al. The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts. Experimental Hematology 2001; 29: 391–400
   PubMed Web of Science ®Google Scholar
• Nouspikel T, Hanawalt P C. DNA repair in terminally differentiated cells. DNA Repair (Amsterdam) 2002; 1: 59–75
   PubMed Web of Science ®Google Scholar
• Biernaux C, Sels A, Huez G, Stryckmans P. Very low level of major BCR-ABL expression in blood of some healthy individuals. Bone Marrow Transplant 1996; 17(Suppl 3)S45–S47
   PubMed Web of Science ®Google Scholar
• Limpens J, de Jong D, van Krieken J H, Price C G, Young B D, van Ommen G J, Kluin P M. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991; 6: 2271–2276
   PubMed Web of Science ®Google Scholar
• Gurbuxani S, Vyas P, Crispino J D. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood 2004; 103: 399–406
   PubMed Web of Science ®Google Scholar